Nedocromil: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 25: | Line 25: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Nedocromil.svg | |||
File:Nedocromil_3D_spacefill.png | |||
</gallery> | |||
Latest revision as of 01:53, 17 February 2025
Nedocromil is a medication that is classified as a mast cell stabilizer. It is primarily used in the management of asthma and allergic conjunctivitis. The drug works by inhibiting the release of inflammatory mediators from mast cells, thereby reducing inflammation and preventing asthma attacks or allergic reactions.
Etymology[edit]
The term "Nedocromil" is derived from the chemical name of the drug, which is 9-ethyl-6,9-dihydro-4H-pyrano[3,4-g]quinoline-2,8-dicarboxylic acid. The name is a combination of parts of the chemical name, with "Nedo" coming from "9-ethyl-6,9-dihydro" and "cromil" from "4H-pyrano[3,4-g]quinoline-2,8-dicarboxylic acid".
Pharmacology[edit]
Nedocromil works by stabilizing mast cells, which are cells that release inflammatory mediators such as histamine and leukotrienes. By preventing the release of these mediators, nedocromil reduces inflammation and prevents the symptoms of asthma and allergic conjunctivitis.
Uses[edit]
Nedocromil is used in the management of asthma and allergic conjunctivitis. It is typically used as a second-line treatment for these conditions, when other treatments have not been effective. Nedocromil is administered via inhalation for asthma, and as eye drops for allergic conjunctivitis.
Side Effects[edit]
Common side effects of nedocromil include cough, throat irritation, and unpleasant taste. Less common side effects can include headache, nausea, and dizziness. Severe side effects are rare, but can include chest pain, difficulty breathing, and severe allergic reactions.
